ABHI Strategy 2007/2008
Summary
Create and sustain meaningful strategic engagement with UK Government
Campaign to reinforce the value of medical technologies and our industry
Monitor and respond to impact of centralised procurement on competition and innovation in the UK
Influence developments in frameworks governing market entry and access - Device regulation
Influence frameworks governing market entry and access - NHS take-up of technology
Create a world-leading environment for medical technology R&D and support high growth SME’s
Build awareness of industry integrity
Membership and securing our mandate
Create and sustain meaningful strategic engagement with UK Government
Ensure dialogue with all Government departments on relevant and appropriate issues
Establish industry representation where required
Provide industry assistance where appropriate to ensure that relevant Government initiatives positively interact
Further develop data to profile industry performance
Campaign to reinforce the value of medical technologies and our industry
Communication with all healthcare stakeholders, including Parliamentarians, clinicians, patient groups and regulatory and enforcement bodies
Demonstrate impact of industry on broader economy and links to wider manufacturing
- Highlight role of industry in training and education, including the contribution to quality and patient safety
Monitor and respond to impact of centralised procurement on competition and innovation in the UK
- Develop policy on role of markets in delivering value to consumers and purchasers
- Respond as appropriate where questions arise over interpretation of public procurement and competition law
- Ensure effective cross-industry/Government working in the development of guidance for procurement processes
Influence developments in frameworks governing market entry and access - Device regulation
- Work to ensure that EU & UK legislation is appropriate for the medical technology industry balancing risk/benefit issues. Activities will include focus on the revision of the Medical Devices Directives (MDD) and the development of Advanced Therapy Medical Products (ATMP) regulation
Monitor the development of policies related to ‘Patient Safety’ including decontamination, reprocessing and auto-identification (AIDC) - Provide industry input into environmental legislation and communicate business impacts
- Ensure that Standardisation, including the system of harmonised standards, continues to underpin the ‘New Approach’
Influence frameworks governing market entry and access - NHS take-up of technology
- Work for appropriate process transparency for Health Technology Assessment (HTA).
- Provide information for Payment by Results system and highlight impact on other policy strands such as procurement, innovation and development of commissioning
Create a world-leading environment for medical technology R&D and support high growth SME’s
- Increase understanding of how innovation works in UK market
- Encourage a robust and continuous pipeline for funding innovations
Improve links to financial community - Stimulate business skills development in early stage companies
- Provide support for UK exporters
Build awareness of industry integrity
- Development and implement standards/codes of conduct
- Professional development of members
- Professional development of representation
Membership and securing our mandate
- Expand our membership
- Improve membership feedback mechanisms
- Continue to develop communication mechanisms to better inform members